These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 31726079)
1. Snakebite envenoming in French Guiana: Assessment of the preclinical efficacy against the venom of Bothrops atrox of two polyspecific antivenoms. Resiere D; Villalta M; Arias AS; Kallel H; Nèviére R; Vidal N; Mehdaoui H; Gutiérrez JM Toxicon; 2020 Jan; 173():1-4. PubMed ID: 31726079 [TBL] [Abstract][Full Text] [Related]
2. Antivenomics and in vivo preclinical efficacy of six Latin American antivenoms towards south-western Colombian Bothrops asper lineage venoms. Mora-Obando D; Pla D; Lomonte B; Guerrero-Vargas JA; Ayerbe S; Calvete JJ PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009073. PubMed ID: 33524033 [TBL] [Abstract][Full Text] [Related]
4. Preclinical efficacy against toxic activities of medically relevant Bothrops sp. (Serpentes: Viperidae) snake venoms by a polyspecific antivenom produced in Mexico. Segura Á; Herrera M; Vargas M; Villalta M; Uscanga-Reynell A; León G; Gutiérrez JM Rev Biol Trop; 2017 Mar; 65(1):345-50. PubMed ID: 29466649 [TBL] [Abstract][Full Text] [Related]
5. Neutralization of four Peruvian Bothrops sp. snake venoms by polyvalent antivenoms produced in Perú and Costa Rica: preclinical assessment. Rojas E; Quesada L; Arce V; Lomonte B; Rojas G; Gutiérrez JM Acta Trop; 2005 Jan; 93(1):85-95. PubMed ID: 15589801 [TBL] [Abstract][Full Text] [Related]
6. Toxicity of Bothrops sp snake venoms from Ecuador and preclinical assessment of the neutralizing efficacy of a polyspecific antivenom from Costa Rica. Laines J; Segura Á; Villalta M; Herrera M; Vargas M; Alvarez G; Gutiérrez JM; León G Toxicon; 2014 Sep; 88():34-7. PubMed ID: 24950051 [TBL] [Abstract][Full Text] [Related]
7. Venom of Bothrops asper from Mexico and Costa Rica: intraspecific variation and cross-neutralization by antivenoms. Segura A; Herrera M; Villalta M; Vargas M; Uscanga-Reynell A; de León-Rosales SP; Jiménez-Corona ME; Reta-Mares JF; Gutiérrez JM; León G Toxicon; 2012 Jan; 59(1):158-62. PubMed ID: 22119752 [TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of three polyspecific antivenoms against the venom of Echis ocellatus: Neutralization of toxic activities and antivenomics. Calvete JJ; Arias AS; Rodríguez Y; Quesada-Bernat S; Sánchez LV; Chippaux JP; Pla D; Gutiérrez JM Toxicon; 2016 Sep; 119():280-8. PubMed ID: 27377229 [TBL] [Abstract][Full Text] [Related]
9. Development of Nanobodies Against Hemorrhagic and Myotoxic Components of Bailon Calderon H; Yaniro Coronel VO; Cáceres Rey OA; Colque Alave EG; Leiva Duran WJ; Padilla Rojas C; Montejo Arevalo H; García Neyra D; Galarza Pérez M; Bonilla C; Tintaya B; Ricciardi G; Smiejkowska N; Romão E; Vincke C; Lévano J; Celys M; Lomonte B; Muyldermans S Front Immunol; 2020; 11():655. PubMed ID: 32457735 [TBL] [Abstract][Full Text] [Related]
10. Immunological profile of antivenoms: preclinical analysis of the efficacy of a polyspecific antivenom through antivenomics and neutralization assays. Gutiérrez JM; Lomonte B; Sanz L; Calvete JJ; Pla D J Proteomics; 2014 Jun; 105():340-50. PubMed ID: 24583507 [TBL] [Abstract][Full Text] [Related]
11. Clinical Features and Management of Snakebite Envenoming in French Guiana. Resiere D; Houcke S; Pujo JM; Mayence C; Mathien C; NkontCho F; Blaise N; Demar MP; Hommel D; Kallel H Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33086750 [TBL] [Abstract][Full Text] [Related]
12. Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms. Segura A; Castillo MC; Núñez V; Yarlequé A; Gonçalves LR; Villalta M; Bonilla C; Herrera M; Vargas M; Fernández M; Yano MY; Araújo HP; Boller MA; León P; Tintaya B; Sano-Martins IS; Gómez A; Fernández GP; Geoghegan P; Higashi HG; León G; Gutiérrez JM Toxicon; 2010 Nov; 56(6):980-9. PubMed ID: 20621114 [TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin G and F(ab')2 polyvalent antivenoms do not differ in their ability to neutralize hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom. León G; Rojas G; Lomonte B; Gutiérrez JM Toxicon; 1997 Nov; 35(11):1627-37. PubMed ID: 9428109 [TBL] [Abstract][Full Text] [Related]
15. Toxicological profile of medically relevant Crotalus species from Mexico and their neutralization by a Crotalus basiliscus/Bothrops asper antivenom. Sánchez M; Solano G; Vargas M; Reta-Mares F; Neri-Castro É; Alagón A; Sánchez A; Villalta M; León G; Segura Á Toxicon; 2020 May; 179():92-100. PubMed ID: 32345455 [TBL] [Abstract][Full Text] [Related]
16. Preclinical assessment of the ability of polyvalent (Crotalinae) and anticoral (Elapidae) antivenoms produced in Costa Rica to neutralize the venoms of North American snakes. Arce V; Rojas E; Ownby CL; Rojas G; Gutiérrez JM Toxicon; 2003 Jun; 41(7):851-60. PubMed ID: 12782085 [TBL] [Abstract][Full Text] [Related]
17. Ability of six Latin American antivenoms to neutralize the venom of mapaná equis (Bothrops atrox) from Antioquia and Chocó (Colombia). Otero R; Nuñez V; Osorio RG; Gutiérrez JM; Giraldo CA; Posada LE Toxicon; 1995 Jun; 33(6):809-15. PubMed ID: 7676472 [TBL] [Abstract][Full Text] [Related]
18. [(Evaluation of neutralizing ability of four commercially available antivenoms against the venom of Bothrops asper from Costa Rica)]. Bogarín G; Segura E; Durán G; Lomonte B; Rojas G; Gutiérrez JM Toxicon; 1995 Sep; 33(9):1242-7. PubMed ID: 8585095 [TBL] [Abstract][Full Text] [Related]
19. [Study on the venoms of the principal venomous snakes from French Guiana and the neutralization]. Estévez J; Magaña P; Chippaux JP; Vidal N; Mancilla R; Paniagua JF; de Roodt AR Bull Soc Pathol Exot; 2008 Oct; 101(4):353-9. PubMed ID: 18956820 [TBL] [Abstract][Full Text] [Related]
20. Use of freeze-dried trivalent antivenom to neutralize the toxic activities of Bothrops atrox snake venoms from the Amazon. Muniz EG; Oliveira SS; Noronha MDDN; Saraiva MDGG; Sano-Martins IS Toxicon; 2021 Sep; 200():19-22. PubMed ID: 34214579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]